---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-016685"
form_type: "8-K"
ticker: "STXS"
cik: "0001289340"
company_name: "Stereotaxis, Inc."
filed_at: "2026-04-15T23:59:59+00:00"
generated_at: "2026-05-15T06:01:50.153821+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Stereotaxis to acquire Robocath for $20M initial plus up to $25M in earnouts

## Summary
- Total consideration up to $45M: $20M upfront (cash/stock) plus earnouts of $10M (FDA approval) and $15M (commercial milestones).
- Expected close in July 2026, subject to French regulatory clearance and Stereotaxis debt restructuring.
- Interim financing of approx. €1.3M provided to Robocath between signing and closing.
- Stock consideration capped at 19.9% of outstanding shares pre-closing unless shareholder approval obtained.
- Earnout targets based on next-gen interventional device FDA approval and specified product sales thresholds.

## SEC filing metadata
- accession: 0001493152-26-016685
- form_type: 8-K
- ticker: STXS
- cik: 0001289340
- company_name: Stereotaxis, Inc.
- filed_at: 2026-04-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289340/000149315226016685/0001493152-26-016685-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289340/000149315226016685/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-016685
- JSON: https://secwatch.observer/filing/0001493152-26-016685.json
- Plain text: https://secwatch.observer/filing/0001493152-26-016685.txt

## Source-grounded claims
- claim_id: 7003c10c611a48aea9a698ec6a0b4c582e814f51
  claim: Stereotaxis, Inc. entered into Share Sale Agreement with Robocath, the Sellers, and the Manager valued at $20.0 million (effective 2026-04-14).
  evidence_excerpt: On April 14, 2026, Stereotaxis, Inc. (“Stereotaxis” or the “Company”) entered into a Share Sale Agreement with Robocath, a French société par actions simplifiée , (“Robocath”), the shareholders of Robocath party thereto (the “Sellers”) and an individual serving as manager (the “Manager”) to acquire (the “Acquisition”) shares and other securities collectively representing 100% of the share capital and voting power of Robocath (on a fully-diluted basis) (the “Robocath Securities”) from the Sellers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1289340/000149315226016685/0001493152-26-016685-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.